Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2020 Full year and fourth quarter results announcement
We will announce our full year and fourth quarter 2020 results at 12:00 GMT, 07:00 EST on Wednesday 3 February 2021.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, Iain Mackay, CFO, and Dr Hal Barron, Chief Scientific Officer and President of R&D, at 14:00 GMT, 09:00 EST.
Latest information
Press releases for media
- GSK and Novartis announce collaboration to support scientific research into genetic diversity in Africa
- GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancers at ASCO Gastrointestinal Cancers Symposium
- ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe
- Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
Sign up for announcements
Sign up to receive email notifications when we publish a stock exchange announcement.
Annual Report 2019
We published our Annual Report 2019 on 04 March 2020. View the summary and download the full report or individual sections.